Bisphenol A induces non-alcoholic fatty liver disease by promoting the O-GlcNAcylation of NLRP3

References

• An, S.J., et al., 2021. The association between urinary bisphenol A levels and nonalcoholic fatty liver disease in Korean adults: Korean National Environmental Health Survey (KoNEHS) 2015–2017. Environmental Health and Preventive Medicine, 26 (1), 91.
   PubMed Web of Science ®Google Scholar
• Benhamed, F., et al., 2014. O-GlcNAcylation links ChREBP and FXR to glucose-sensing. Frontiers in endocrinology, 5, 230. doi: 10.3389/fendo.2014.00230.
   PubMed Web of Science ®Google Scholar
• Brainard, R.E., and Facundo, H.T., 2021. Cardiac hypertrophy drives PGC-1α suppression associated with enhanced O-glycosylation. Biochimica et biophysica acta molecular basis of disease, 1867 (5), 166080. doi: 10.1016/j.bbadis.2021.166080.
   PubMed Web of Science ®Google Scholar
• Chakraborty, S., et al., 2023. Ancestral BPA exposure caused defects in the liver of medaka for four generations. The science of the total environment, 856 (Pt 1), 159067. doi: 10.1016/j.scitotenv.2022.159067.
   PubMedGoogle Scholar
• Chatham, J.C., Zhang, J., and Wende, A.R., 2021. Role of O-linked N-acetylglucosamine protein modification in cellular (Patho)physiology. Physiological reviews, 101 (2), 427–493. doi: 10.1152/physrev.00043.2019.
   PubMed Web of Science ®Google Scholar
• Dallio, M., et al., 2019. Chemical effect of bisphenol A on non-alcoholic fatty liver disease. International journal of environmental research and public health, 16 (17), 3134.
   PubMed Web of Science ®Google Scholar
• Dallio, M., et al., 2018. Role of bisphenol A as environmental factor in the promotion of non-alcoholic fatty liver disease: in vitro and clinical study. Alimentary pharmacology & therapeutics, 47 (6), 826–837. doi: 10.1111/apt.14499.
   PubMed Web of Science ®Google Scholar
• Deprince, A., Haas, J.T., and Staels, B., 2020. Dysregulated lipid metabolism links NAFLD to cardiovascular disease. Molecular metabolism, 42, 101092. doi: 10.1016/j.molmet.2020.101092.
   PubMed Web of Science ®Google Scholar
• Duan, F., et al., 2018. O-GlcNAcylation of RACK1 promotes hepatocellular carcinogenesis. Journal of hepatology, 68 (6), 1191–1202. doi: 10.1016/j.jhep.2018.02.003.
   PubMed Web of Science ®Google Scholar
• Duell, P.B., et al., 2022. Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American heart association. Arteriosclerosis, thrombosis, and vascular biology, 42 (6), e168–e185. doi: 10.1161/ATV.0000000000000153.
   PubMed Web of Science ®Google Scholar
• Fan, Q., et al., 2017. LXRalpha regulates hepatic ChREBPalpha activity and lipogenesis upon glucose, but not fructose feeding in mice. Nutrients, 9 (7), 678. doi: 10.3390/nu9070678.
   PubMed Web of Science ®Google Scholar
• Farrugia, F., et al., 2021. Bisphenol A and type 2 diabetes mellitus: a review of epidemiologic, functional, and early life factors. International journal of environmental research and public health, 18 (2), 716.
   PubMed Web of Science ®Google Scholar
• Gao, Y., et al., 2020. Exercise and dietary intervention ameliorate high-fat diet-induced NAFLD and liver aging by inducing lipophagy. Redox biology, 36, 101635. doi: 10.1016/j.redox.2020.101635.
   PubMed Web of Science ®Google Scholar
• Han, M., Li, S., and Li, L., 2021. Verapamil inhibits early acute liver failure through suppressing the NLRP3 inflammasome pathway. Journal of cellular and molecular medicine, 25 (13), 5963–5975. doi: 10.1111/jcmm.16357.
   PubMed Web of Science ®Google Scholar
• Huang, Y., Xu, W., and Zhou, R., 2021. NLRP3 inflammasome activation and cell death. Cellular & molecular immunology, 18 (9), 2114–2127. doi: 10.1038/s41423-021-00740-6.
   PubMed Web of Science ®Google Scholar
• Ipsen, D.H., Lykkesfeldt, J., and Tveden-Nyborg, P., 2018. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cellular and molecular life sciences, 75 (18), 3313–3327. doi: 10.1007/s00018-018-2860-6.
   PubMed Web of Science ®Google Scholar
• Ji, S., et al., 2012. O-GlcNAc modification of PPARgamma reduces its transcriptional activity. Biochemical and biophysical research communications, 417 (4), 1158–1163. doi: 10.1016/j.bbrc.2011.12.086.
   PubMed Web of Science ®Google Scholar
• Kumar, V., et al., 2021. Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis. Advanced drug delivery reviews, 176, 113888. doi: 10.1016/j.addr.2021.113888.
   PubMed Web of Science ®Google Scholar
• Lakind, J.S., and Naiman, D.Q., 2011. Daily intake of bisphenol A and potential sources of exposure: 2005–2006 National Health and Nutrition Examination Survey. Journal of exposure science & environmental epidemiology, 21 (3), 272–279. doi: 10.1038/jes.2010.9.
   PubMed Web of Science ®Google Scholar
• Lee, D.E., et al., 2019. Curcumin ameliorates nonalcoholic fatty liver disease through inhibition of O-GlcNAcylation. Nutrients, 11 (11), 2702. doi: 10.3390/nu11112702.
   PubMed Web of Science ®Google Scholar
• Lin, Y., et al., 2017. Downregulation of miR-192 causes hepatic steatosis and lipid accumulation by inducing SREBF1: Novel mechanism for bisphenol A-triggered non-alcoholic fatty liver disease. Biochimica et biophysica acta molecular and cell biology of lipids, 1862 (9), 869–882. doi: 10.1016/j.bbalip.2017.05.001.
   PubMed Web of Science ®Google Scholar
• Long, Z., et al., 2021. Gestational bisphenol A exposure induces fatty liver development in male offspring mice through the inhibition of HNF1b and upregulation of PPARgamma. Cell biology and toxicology, 37 (1), 65–84. doi: 10.1007/s10565-020-09535-3.
   PubMed Web of Science ®Google Scholar
• Mridha, A.R., et al., 2017. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. Journal of hepatology, 66 (5), 1037–1046. doi: 10.1016/j.jhep.2017.01.022.
   PubMed Web of Science ®Google Scholar
• Pawlak, M., Lefebvre, P., and Staels, B., 2015. Molecular mechanism of PPARalpha action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease. Journal of hepatology, 62 (3), 720–733. doi: 10.1016/j.jhep.2014.10.039.
   PubMed Web of Science ®Google Scholar
• Peretz, J., et al., 2014. Bisphenol a and reproductive health: update of experimental and human evidence, 2007-2013. Environmental health perspectives, 122 (8), 775–786. doi: 10.1289/ehp.1307728.
   PubMed Web of Science ®Google Scholar
• Pérez-Bermejo, M., Mas-Pérez, I., and Murillo-Llorente, M.T., 2021. The role of the bisphenol A in diabetes and obesity. Biomedicines, 9 (6), 666. doi: 10.3390/biomedicines9060666.
   PubMed Web of Science ®Google Scholar
• Pjanic, M., 2017. The role of polycarbonate monomer bisphenol-A in insulin resistance. PeerJ, 5, e3809. doi: 10.7717/peerj.3809.
   PubMed Web of Science ®Google Scholar
• Rahman, M.A., et al., 2019. Modulation of O-GlcNAcylation regulates autophagy in cortical astrocytes. Oxidative medicine and cellular longevity, 2019, 6279313–6279313. doi: 10.1155/2019/6279313.
   PubMed Web of Science ®Google Scholar
• Riazi, K., et al., 2022. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. The lancet gastroenterology & hepatology, 7 (9), 851–861. doi: 10.1016/S2468-1253(22)00165-0.
   PubMed Web of Science ®Google Scholar
• Shang, M., et al., 2021. The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation. Nature communications, 12 (1), 1940. doi: 10.1038/s41467-021-22173-5.
   PubMed Web of Science ®Google Scholar
• Sheik Abdul, N., Nagiah, S., and Chuturgoon, A.A., 2019. Fusaric acid induces NRF2 as a cytoprotective response to prevent NLRP3 activation in the liver derived HepG2 cell line. Toxicology in vitro, 55, 151–159. doi: 10.1016/j.tiv.2018.12.008.
   PubMed Web of Science ®Google Scholar
• Shi, X., et al., 2023. ROS mediated pyroptosis-M1 polarization crosstalk participates in inflammation of chicken liver induced by bisphenol A and selenium deficiency. Environmental pollution, 324, 121392. doi: 10.1016/j.envpol.2023.121392.
   PubMed Web of Science ®Google Scholar
• Siracusa, J.S., et al., 2018. Effects of bisphenol A and its analogs on reproductive health: A mini review. Reproductive toxicology, 79, 96–123. doi: 10.1016/j.reprotox.2018.06.005.
   PubMed Web of Science ®Google Scholar
• Tan, W., et al., 2021. Posttranscriptional regulation of de novo lipogenesis by glucose-induced O-GlcNAcylation. Molecular cell, 81 (9), 1890–1904.e7. doi: 10.1016/j.molcel.2021.02.009.
   PubMed Web of Science ®Google Scholar
• Unamuno, X., et al., 2021. NLRP3 inflammasome blockade reduces adipose tissue inflammation and extracellular matrix remodeling. Cellular & molecular immunology, 18 (4), 1045–1057. doi: 10.1038/s41423-019-0296-z.
   PubMed Web of Science ®Google Scholar
• Wan, X., et al., 2016. Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH. Canadian journal of gastroenterology & hepatology, 2016, 6489012. doi: 10.1155/2016/6489012.
   PubMed Web of Science ®Google Scholar
• Wang, X., et al., 2021. NLRP3 inflammasome inhibitor CY-09 reduces hepatic steatosis in experimental NAFLD mice. Biochemical and biophysical research communications, 534, 734–739. doi: 10.1016/j.bbrc.2020.11.009.
   PubMed Web of Science ®Google Scholar
• Wei, X., et al., 2020. Posttranslational modifications in ferroptosis. Oxidative medicine and cellular longevity, 2020, 8832043.
   PubMed Web of Science ®Google Scholar
• Wu, J., et al., 2022. Corydalis saxicola Bunting Total Alkaloids ameliorate diet-induced non-alcoholic steatohepatitis by regulating hepatic PI3K/Akt and TLR4/NF-kappaB pathways in mice. Biomedicine & pharmacotherapy = biomedecine & pharmacotherapie, 151, 113132. doi: 10.1016/j.biopha.2022.113132.
   PubMed Web of Science ®Google Scholar
• Wu, N., et al., 2019. O-GlcNAcylation promotes colorectal cancer progression by regulating protein stability and potential catcinogenic function of DDX5. Journal of cellular and molecular medicine, 23 (2), 1354–1362. doi: 10.1111/jcmm.14038.
   PubMed Web of Science ®Google Scholar
• Xie, Z., et al., 2023. Emerging role of protein O-GlcNAcylation in liver metabolism: implications for diabetes and NAFLD. International journal of molecular sciences, 24 (3), 2142. doi: 10.3390/ijms24032142.
   PubMed Web of Science ®Google Scholar
• Xu, T.H., et al., 2020. OGT-mediated KEAP1 glycosylation accelerates NRF2 degradation leading to high phosphate-induced vascular calcification in chronic kidney disease. Frontiers in physiology, 11, 1092. doi: 10.3389/fphys.2020.01092.
   PubMed Web of Science ®Google Scholar
• Yu, X., et al., 2019. Liraglutide ameliorates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome and pyroptosis activation via mitophagy. European journal of pharmacology, 864, 172715. doi: 10.1016/j.ejphar.2019.172715.
   PubMed Web of Science ®Google Scholar
• Zhang, D., et al., 2017. Lipogenic transcription factor ChREBP mediates fructose-induced metabolic adaptations to prevent hepatotoxicity. The journal of clinical investigation, 127 (7), 2855–2867. doi: 10.1172/JCI89934.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., et al., 2022. Bisphenol A induces pyroptotic cell death via ROS/NLRP3/Caspase-1 pathway in osteocytes MLO-Y4. Food and chemical toxicology, 159, 112772. doi: 10.1016/j.fct.2021.112772.
   PubMed Web of Science ®Google Scholar
• Zhou, J., et al., 2020. Epidemiological features of NAFLD from 1999 to 2018 in China. Hepatology, 71 (5), 1851–1864. doi: 10.1002/hep.31150.
   PubMed Web of Science ®Google Scholar
• Zhou, Y., et al., 2022. O-GlycNacylation remission retards the progression of non-alcoholic fatty liver disease. Cells, 11 (22), 3637. doi: 10.3390/cells11223637.
   PubMed Web of Science ®Google Scholar
• Zhu, Y., et al., 2021. Caspase-11-mediated hepatocytic pyroptosis promotes the progression of nonalcoholic steatohepatitis. Cellular and molecular gastroenterology, 12 (2), 653–664.
   PubMed Web of Science ®Google Scholar